Status:
COMPLETED
Lidocaine Spray Plus Oral Celecoxib for Pain Control During Hysterosalpingography
Lead Sponsor:
Aswan University Hospital
Conditions:
IUCD Complication
Eligibility:
FEMALE
18-45 years
Phase:
NA
Brief Summary
our aims to investigate the effectiveness of10% Lidocaine Spray plus oral celecoxib for Pain Control During Hysterosalpingography
Detailed Description
hysterosalpingography can cause pain and discomfort in several ways: Use of the tenaculum to grasp the cervix and straighten the uterus for proper insertion; trans-cervical actions including measuring...
Eligibility Criteria
Inclusion
- any patient came for Hysterosalpingography
Exclusion
- any patient has contraindication to Hysterosalpingography
Key Trial Info
Start Date :
September 1 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 27 2021
Estimated Enrollment :
150 Patients enrolled
Trial Details
Trial ID
NCT04505657
Start Date
September 1 2020
End Date
September 27 2021
Last Update
September 29 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Aswan University Hospital
Aswān, Egypt, 81528